Skip to content
Home/Companies/Biotech/Quell Therapeutics
Quell Therapeutics

Quell Therapeutics

Biotech·United Kingdom·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Quell Therapeutics?

Quell Therapeutics is a British Biotech company, currently owned by SV Health Managers since 2021 and Jeito Capital.

Hand-verified · updated 2026-05-13

Open JSON · CC-BY
Jeito Capital
Most recent investor
Jeito Capital
Jeito I · 2021 · VC
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by SV Health Managers and Jeito Capital since 2021.
Co-invest · 2 holders · 2021 · present
SV Health Managers
2021 · present(5yr) · SV7 Impact Medicine Fund · 2019 · Life Sciences VC
Jeito Capital
2021 · present(5yr) · Jeito I · 2021 · VC

Questions

Who owns Quell Therapeutics?

Quell Therapeutics is currently owned by SV Health Managers and Jeito Capital, through Jeito I, since 2021.

When did SV Health Managers and 1 other acquire Quell Therapeutics?

SV Health Managers and 1 other acquired Quell Therapeutics in 2021.

Who has owned Quell Therapeutics over time?

Quell Therapeutics has been through 2 private-equity ownership periods: SV Health Managers · via SV7 Impact Medicine Fund · since 2021; Jeito Capital · via Jeito I · since 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue